OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal Cancer

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdz171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Evaluation of Pemetrexed and Etoposide as Therapeutic Regimens for Human Papillomavirus-Positive Oral and Oropharyngeal Cancer

PLoS ONE
Multidisciplinary
2018English

Biology of Human Papillomavirus–Related Oropharyngeal Cancer

Seminars in Radiation Oncology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2012English

Educational Case: Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma

Academic Pathology
Forensic MedicinePathology
2019English

Efficacy of EZH2 Inhibitory Drugs in Human Papillomavirus-Positive and Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinomas

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2017English

Human Papillomavirus–Positive Oral Cavity and Oropharyngeal Cancer Patients Do Not Have Better Quality-Of-Life Trajectories

Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2012English

A Phase I Dose-Escalation Trial of Stereotactic Body Radiotherapy Using 4 Fractions for Patients With Localized Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Societal Cost of Oropharyngeal Cancer by Human Papillomavirus Status, Cancer Stage, and Subsite

PLoS ONE
Multidisciplinary
2019English

Human Papillomavirus DNA Detection in Fine-Needle Aspirates as Indicator of Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma: A Prospective Study

Head and Neck
Otorhinolaryngology
2016English

A Phase I/Ii Seamless Dose Escalation/Expansion With Adaptive Randomization Scheme (SEARS)

Clinical Trials
MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy